School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
Institute of Systems Biology, Universiti Kebangsaan Malaysia, Bangi 43600, Malaysia.
Molecules. 2022 Jun 7;27(12):3670. doi: 10.3390/molecules27123670.
Phillyrin is an effective lignan glycoside extracted from a traditional Chinese medicine (Thunb.) Vahl (Oleaceae). It mainly exists in the roots, stems, leaves and fruits of the plant, with the highest content in the leaves. In terms of its medicinal application, there are a large number of experimental data proving its pharmacological effects in vitro and in animal models, such as anti-inflammatory, anti-obesity, anti-tumor, etc. Furthermore, pharmacokinetic experiments have also shown phillyrin's high effectiveness and low toxicity. Despite more than one thousand studies in the literature on phillyrin retrievable from Web of Science, PubMed, and CNKI, few reviews on its pharmacological activities have been presented conclusively. In this paper, we aimed to summarize the pharmacological and pharmacokinetic characteristics of phillyrin from the current literature, focusing on its anti-inflammatory, anti-aging, antiviral, antibacterial, hepatoprotective and anti-cancer effects, hoping to come up with new insights for its application as well as future studies.
朝藿定 C 是从传统中药(Thunb.)Vahl(木犀科)中提取的一种有效的木脂素糖苷。它主要存在于植物的根、茎、叶和果实中,在叶子中的含量最高。就其药用应用而言,有大量的实验数据证明了它在体外和动物模型中的药理作用,如抗炎、抗肥胖、抗肿瘤等。此外,药代动力学实验也表明朝藿定 C 的高效性和低毒性。尽管从 Web of Science、PubMed 和 CNKI 中可检索到超过一千篇关于朝藿定 C 的文献,但很少有综述能明确其药理活性。在本文中,我们旨在从现有文献中总结朝藿定 C 的药理和药代动力学特征,重点介绍其抗炎、抗衰老、抗病毒、抗菌、保肝和抗癌作用,希望为其应用及未来研究提供新的思路。